Red blood cell molecular abnormalities in non haematological diseases.
Literature regarding molecular abnormalities of red blood cells (RBCs) that do not affect cell morphology, function or life span, observed in several non haematological diseases, has been reviewed with the aim of pointing out the pathological conditions in which RBC studies may offer useful biological and/or clinical information. RBC abnormalities have been classified into membrane and cytoplasm alterations; lipid and protein alterations of the membrane have been considered separately. We conclude that RBCs may often provide a simple and reliable tool for investigations concerning the diagnosis and/or treatment of many diseases, even if in some cases the true biological and clinical value of the remarks has to be evaluated further.
De Sandre
G
G
Istituto di Patologia Speciale Medica, Università, Verona, Italy.
Girelli
D
D
Olivieri
O
O
D001327:Autoimmune Diseases / Q000097:blood*; D002352:Carrier Proteins / Q000032:analysis; D003593:Cytoplasm / Q000737:chemistry; D004910:Erythrocyte Membrane / Q000648:ultrastructure; D004913:Erythrocytes, Abnormal / Q000737:chemistry* / Q000648:ultrastructure; D030342:Genetic Diseases, Inborn / Q000097:blood*; D006801:Humans; D007674:Kidney Diseases / Q000097:blood; D008563:Membrane Lipids / Q000032:analysis; D008565:Membrane Proteins / Q000032:analysis; D001523:Mental Disorders / Q000097:blood*; D008659:Metabolic Diseases / Q000097:blood*; D011956:Receptors, Cell Surface / Q000032:analysis
D002352:Carrier Proteins; D008563:Membrane Lipids; D008565:Membrane Proteins; D011956:Receptors, Cell Surface